DNAJC5 and parasitic infectious disease: No significant differences were observed between P and NP within either SC1 or SC2-4 for any dose group for CSP-specific IgG, weight-for-age, age, sex, parasitemia at first vaccination, or study site (Supplemental Figure 2, C–I).